









Markets
/
Stocks
/
nasdaq-md
/

Pediatrix Medical Group Inc

22.199USD

+1.119+5.31%

Market hours （ET）Quotes delayed by 15 min

1.93BMarket Cap

17.54P/E TTM



Pediatrix Medical Group Inc

22.199

+1.119+5.31%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Pediatrix Medical Group Inc

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pediatrix Medical Group Inc's Score

Industry at a Glance

Industry Ranking

3 / 78

Overall Ranking

48 / 4617

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

16.750

Target Price

-1.30%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Pediatrix Medical Group Inc Highlights

StrengthsRisks

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Overvalued

The company’s latest PE is 16.05, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 85.12M shares, decreasing 3.34% quarter-over-quarter.

Held by John Hussman

Star Investor John Hussman holds 210.00K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.16.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 7.92, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 468.84M, representing a year-over-year decrease of 7.03%, while its net profit experienced a year-over-year decrease of 125.66%.

Score

Industry at a Glance

Previous score

7.92

Change



Financials

6.46

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.93

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.28

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.75

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.19

Key Metrics

Free cash flow

No Data

Pediatrix Medical Group Inc's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 8.68, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 16.05, which is 30.99% below the recent high of 21.03 and 195.28% above the recent low of -15.29.

Score

Industry at a Glance

Previous score

8.68

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 3/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 7.14, which is lower than the Healthcare Providers & Services industry's average of 7.56. The average price target for Pediatrix Medical Group Inc is 17.00, with a high of 19.00 and a low of 13.00.

Score

Industry at a Glance

Previous score

7.14

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

16.750

Target Price

-1.30%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Pediatrix Medical Group Inc

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 9.65, which is higher than the Healthcare Providers & Services industry's average of 6.93. Sideways: Currently, the stock price is trading between the resistance level at 22.98 and the support level at 17.44, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.31

Change

2.34

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.525

Buy

RSI(14)

76.941

Buy

STOCH(KDJ)(9,3,3)

69.341

Neutral

ATR(14)

0.741

High Vlolatility

CCI(14)

311.505

Overbought

Williams %R

3.068

Overbought

TRIX(12,20)

0.294

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

18.230

Buy

MA10

17.738

Buy

MA20

17.112

Buy

MA50

16.913

Buy

MA100

15.351

Buy

MA200

14.708

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 97.74%, representing a quarter-over-quarter increase of 5.19%. The largest institutional shareholder is The Vanguard, holding a total of 10.92M shares, representing 12.54% of shares outstanding, with 0.37% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

12.03M

-4.12%

The Vanguard Group, Inc.

Star Investors

10.92M

+1.76%

State Street Investment Management (US)

3.49M

-1.04%

Dimensional Fund Advisors, L.P.

3.32M

+4.66%

Victory Capital Management Inc.

3.16M

+4616.08%

Fidelity Management & Research Company LLC

2.41M

-16.95%

Geode Capital Management, L.L.C.

2.00M

-0.76%

American Century Investment Management, Inc.

1.93M

+28.63%

AllianceBernstein L.P.

1.84M

-4.64%

D. E. Shaw & Co., L.P.

1.58M

-15.73%

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 6.86, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.20. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.